You are here
TGA business plan 2020-21
The TGA Business Plan sets out our product regulation, regulatory reform, international engagement and regulatory compliance agenda for 2020–21 and the steps we will take to achieve our vision. It also supplements the Health Portfolio Budget Statements and the Department of Health Corporate Plan and is supported by the Australian Government's Regulator Performance Framework.
The TGA Business Plan provides details on our key deliverables in relation to the regulation of therapeutic goods, and should be read in concert with our performance reporting.
- Strategic framework
- The implications of COVID-19
- Product regulation
- International engagement
We aim to provide documents in an accessible format. If you are having problems using a document with your accessibility tools, please contact us for help.